Vaneet Sandhu

Company: Fate Therapeutics

Job title: Vice President Clinical Development, Autoimmunity

Seminars:

Treatment of Refractory Systemic Lupus Erythematosus with iPSC-derived Off-the-Shelf Anti-CD19 CAR T-cell Therapy 9:30 am

Brief review of CAR iT cell (FT819) product configuration and clinical oncology data Review of FT819 preclinical and clinical rheumatology data Brief overview of CAR iNK cell (FT522) product configuration and rheumatology data NEW DATARead more

day: Day Two AM